Not exact matches
ESCR scientists are mounting a furious political assault against the lawsuit, currently back
in Royce Lamberth's court urging that human
embryonic stem cell research continue to be funded by the Feds, hoping to pressure the judge to see it their
way.
(
In many ways it is worse than when John Edwards said in 2004 that if people voted for John Kerry, people like Christopher Reeve would get out of their wheelchairs and walk from embryonic stem cell therapies
In many
ways it is worse than when John Edwards said
in 2004 that if people voted for John Kerry, people like Christopher Reeve would get out of their wheelchairs and walk from embryonic stem cell therapies
in 2004 that if people voted for John Kerry, people like Christopher Reeve would get out of their wheelchairs and walk from
embryonic stem cell therapies.)
But the methods used to reprogram
cells can damage their DNA, and the iPS
cells may not behave
in exactly the same
way as
embryonic stem cells.
The act of reprogramming
cells to make them as capable as ones from embryos apparently can result
in aberrant
cells that age and die abnormally, suggesting there is a long
way to go to prove such
cells are really like
embryonic stem cells and can find use
in therapies.
In this
way they act like
embryonic stem cells and share their revolutionary therapeutic potential — and as such, they could eliminate the need for using and then destroying human embryos.
In 2004 they devised a
way to coax
embryonic stem cells to turn into transplantable RPE tissue.
In an advance touted as a
way around current political logjams, scientists have said they can derive human
embryonic stem (ES)
cell lines without destroying an embryo.
On the other hand, the problem is, you know, with
embryonic stem cells, they haven't been able to get
stem cell lines from livestock animals that can proliferate
in that
way, without just sort of veering up
in their own direction and turning into, instead of muscle, turning into brain tissue or bone tissue or something else.
In the past few months, researchers in the United States and Japan have described a promising way of deriving embryonic stem cells from skin cells (of mice) without destroying embryos — the «Holy Grail of biotechnology,» as The Times of London put i
In the past few months, researchers
in the United States and Japan have described a promising way of deriving embryonic stem cells from skin cells (of mice) without destroying embryos — the «Holy Grail of biotechnology,» as The Times of London put i
in the United States and Japan have described a promising
way of deriving
embryonic stem cells from skin
cells (of mice) without destroying embryos — the «Holy Grail of biotechnology,» as The Times of London put it.
In 2008 a group of medical researchers led by Robert Lanza at Advanced Cell Technology in Worcester, Massachusetts, reported another leap: They discovered a way to avoid destroying the embryo by deriving an entire stem cell line from a single embryonic cel
In 2008 a group of medical researchers led by Robert Lanza at Advanced
Cell Technology in Worcester, Massachusetts, reported another leap: They discovered a way to avoid destroying the embryo by deriving an entire stem cell line from a single embryonic c
Cell Technology
in Worcester, Massachusetts, reported another leap: They discovered a way to avoid destroying the embryo by deriving an entire stem cell line from a single embryonic cel
in Worcester, Massachusetts, reported another leap: They discovered a
way to avoid destroying the embryo by deriving an entire
stem cell line from a single embryonic c
cell line from a single
embryonic cellcell.
Because biologists like Daley are convinced that
embryonic stem cells — the most generic, versatile type — may not only lead to dramatically different new treatments but can also uniquely illuminate the origins of disease
in a
way adult
stem cells never will.
They view this as a test run for creating human
embryonic stem cells in the same
way (and according to the team, South Korean biologist Hwang Woo Suk seems to have accidentally accomplished this feat while executing his famously fraudulent human cloning experiment).
The ethics council finally issued its 20 - page report just before Christmas, voting
in favor of allowing the import of human
embryonic stem cells, under certain conditions, by a small majority of 15 to 9, paving the
way for next week's final showdown.
The result — the second such finding
in the past year — suggests that similar
cells from human testicles might have similar powers, paving the
way to creating replacement tissue for men who have suffered damage from heart attacks or other injuries and avoiding some of the controversy surrounding
embryonic stem cells (ESC).
Twenty percent of the
cells cloned
in this
way grew into early embryos, called blastocysts, and 5 percent of them yielded
embryonic stem cells, which is comparable with results obtained from unfertilized eggs.
When current methods for generating naïve
stem cells in the lab were judged using the three tests, each fell short of mimicking the naïve
embryonic cells in different
ways.
For these
cells to be as useful as
embryonic stem cells, «we have to find a
way to avoid retroviruses before application
in cell therapy», Yamanaka says, as they could result
in tumours.
But of course, posed this
way the question does not distinguish between
stem cells obtained
in different
ways (and indeed it is sensible to assume that those who expressed opposition
in response to this question believed they were being asked about
embryonic stem cells, although the survey does not allow us to know that with confidence).
To appreciate the difference, consider that the old
way involves introducing DNA into mouse
embryonic stem cells, and then selecting for the rare
cells that take up and incorporate the DNA
in the right
way.
And
in a
way, this is not very radical because that's what Bush said
in August of 2001 when he became the first president to authorize federal funds for
embryonic stem cell research.
Reprogramming adult
cells to function like
embryonic stem cells is one
way researchers hope to create patient - specific
cell lines to regenerate tissue or to study specific diseases
in the laboratory.
This approach to derive patient - specific
Embryonic Stem cell - like
cells (iPS
cells) is going to open up research into the genetic causes of disease and the search for therapies not only for such diseases, but also for repairing tissues damaged
in other
ways.
Instead, they were searching for
ways to make
embryonic stem cells, a type of
cell that can turn into any
cell type
in the body.
In recent years, researchers have tried to find
ways to obtain
embryonic stem cells without destroying the embryos.
«Having a very efficient and practical
way of generating patient - specific
stem cells, which unlike human
embryonic stem cells, wouldn't be rejected by the patient's immune system after transplantation brings us a step closer to the clinical application of
stem cell therapy,» says Belmonte, PhD., a professor
in the Gene Expression Laboratory and director of the Center of Regenerative Medicine
in Barcelona, Spain.
Although these
cells meet the defining criteria for pluripotent
stem cells, it is not known if iPSCs and
embryonic stem cells differ
in clinically significant
ways.
* The role of the US
in global efforts to address pollutants that are broadly dispersed across national borders, such as greenhouse gasses, persistent organic pollutants, ozone, etc...; * How they view a president's ability to influence national science policy
in a
way that will persist beyond their term (s), as would be necessary for example to address global climate change or enhancement of science education nationwide; * Their perspective on the relative roles that scientific knowledge, ethics, economics, and faith should play
in resolving debates over
embryonic stem cell research, evolution education, human population growth, etc... * What specific steps they would take to prevent the introduction of political or economic bias
in the dissemination and use of scientific knowledge; * (and many more...)
Researchers announced they mimicked the
way embryonic stem cells develop into heart muscle
in a lab.